Piramal Critical Care (PCC), a business unit of Piramal Pharma, is the third largest producer of inhaled anesthetics and a global player in hospital generics. ‘Save lives with critical care solutions’ is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers across the globe, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe, and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics and Intrathecal Baclofen therapy for spasticity management. Our products include Sevoflurane, Isoflurane and Gablofen®.